D-1137-2016 Class I Ongoing
FDA drug recall D-1137-2016 was initiated by Hospira Inc. on Mar 23, 2016 and is designated Class I. Reason for recall: Presence of Particulate Matter: Confirmed customer complaint for the presence of particulate matter. The recall status is ongoing. Affected quantity: 88,500 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 13, 2016
- Initiation Date
- Mar 23, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 88,500 vials
Product description
Magnesium Sulfate Inj., USP 50%, 10 g/20 mL (0.5 g/mL), (4 mEq Magnesium/mL, 20 mL Single-dose vial, packaged in 25 vials per box, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2168-02, barcode (01) 2 030409 216802 5.
Reason for recall
Presence of Particulate Matter: Confirmed customer complaint for the presence of particulate matter.
Distribution pattern
Nationwide, United Arab Emirates, Kuwait, and Bahrain
Code information
Lot #: 50-343-DK*, Exp 01FEB2017; note that the lot number may be followed by numbers from 01 to 99.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1137-2016
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Hospira Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.